SOURCE: Xtalks

Xtalks Webinars

November 02, 2015 15:00 ET

Top News Stories You Might Have Missed From Xtalks

Xtalks Provides Current Articles Daily in the Life Science Industry

TORONTO, ON--(Marketwired - November 02, 2015) - Check out all news stories here: http://xtalks.com/News.ashx. Subscribe to our weekly newsletter: http://register.xtalks.com/newsblogs.

Proposed Megamerger Between Pfizer and Allergan -- http://ow.ly/U8iAz
(Nov 2) Should the companies proceed with the merger, some have speculated that US-based Pfizer would relocate to Ireland -- currently the home of Allergan -- in order to take advantage of a lower tax rate.

Repros Low Testosterone Treatment Faces Another FDA Hurdle -- http://ow.ly/U8iDL
(Nov 2) Repros Therapeutics' low testosterone treatment -- Androxal -- has hit another Food and Drug Administration (FDA) roadblock.

Gilead's Hepatitis C Drug Submitted for FDA Review -- http://ow.ly/U8iJ5
(Oct 30) As Gilead Sciences' two approved therapies for hepatitis C have been billion-dollar successes, the company plans to launch a third treatment option which could be more effective at treating a wider range of patients with the disease.

Herpes Infection More Common Than Previously Thought -- http://ow.ly/U8iNt
(Oct 30) Recent research shows that over 3.7 billion people under the age of 50 are infected with the virus that commonly causes 'cold sores' and is capable of causing genital herpes -- herpes simplex virus type 1.

Widely-Used Acid Reflux Drugs Could Increase Risk Of Kidney Disease -- http://ow.ly/U8iQo
(Oct 29) According to two new studies -- to be presented at ASN Kidney Week 2015 November 3-8 at the San Diego Convention Center in San Diego, CA -- certain popular acid reflux medications could increase an individual's risk of developing kidney disease.

Snake Venom-Containing Hydrogels To Control Bleeding -- http://ow.ly/U8iSO
(Oct 29) Rice University scientists have developed a nanofiber hydrogel containing snake venom, as a procoagulant to be used to control bleeding.

Shire Sees Phase III Success With Its Previously-Rejected Eye Drug -- http://ow.ly/U8iWu
(Oct 28) Specialty biopharmaceutical company, Shire, believes data from its recently-completed Phase III trial for the experimental eye drug, lifitegrast, will allow the company to apply for Food and Drug Administration (FDA) approval early next year.

Sanofi's New CEO Expected To Announce Long Term Plan Next Month -- http://ow.ly/U8iZZ
(Oct 28) Sanofi's new CEO -- Oliver Brandicourt -- is expected to present his five-year strategic plan for the company's future, on November 6.

Processed Meats Linked to Increased Risk of Cancer -- http://ow.ly/U8j2X
(Oct 27) According to the World Health Organization (WHO), consumption of just 50 grams of processed meat per day increases an individual's risk of developing colorectal cancer by 18 percent.

New Treatment for Pancreatic Cancer Approved By FDA -- http://ow.ly/U8j6a
(Oct 27) A press release published by the Food and Drug Administration (FDA) last week detailed the approval of Onivyde (irinotecan liposome injection) for the treatment of advanced stage pancreatic cancer.

Potential Link Between Antibiotic Use and Childhood Obesity -- http://ow.ly/U8j98
(Oct 26) Patients with inflammatory bowel disease -- such as Crohn's and ulcerative colitis -- often receive their medications through drug-based enemas, which can take hours to be fully absorbed by the lining of the colon.

Ultrasound Drug Delivery For Inflammatory Bowel Disease -- http://ow.ly/U8jcd
(Oct 26) Patients with inflammatory bowel disease -- such as Crohn's and ulcerative colitis -- often receive their medications through drug-based enemas, which can take hours to be fully absorbed by the lining of the colon.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners (from pharmaceutical & biotech companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com.

For information about hosting a webinar visit http://xtalks.com/sponsorship.ashx.

Contact Information